Newsmax (NMAX) debuted on the New York Stock Exchange on Monday, selling 7.5 million Class B shares at $10 apiece.
Shares surged 550% as intraday trading volume catapulted to over 4.68 million.
Corcept Therapeutics (CORT) shares soared 87% after the company said its phase 3 trial of relacorilant plus nab-paclitaxel to treat a type of ovarian cancer met its primary goal.
Piper Sandler raised Corcept's price target to $128 from $78 while maintaining its overweight rating.
More than 9.33 million shares of Corcept traded intraday compared with a daily average of about 1.01 million.
Newton Golf (NWTG) reported a year-over-year increase Monday of 817% in its Q4 net sales.
Shares advanced 35%, with intraday trading volume rising to over 47.5 million compared with a daily average of more than 1.16 million.
Price: 66.12, Change: +56.12, Percent Change: +561.24
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.